Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence

Science

Volumn 341, Issue 6152, 2013, Pages 1394-1399

  Corder, G ^a   Doolen, S ^a   Donahue, R R ^a   Winter, M K ^b   Jutras, B L ^a   He, Y ^c   Hu, X ^c   Wieskopf, J S ^d   Mogil, J S ^d   Storm, D R ^e   Wang, Z J ^c   McCarson, K E ^b   Taylor, B K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; ENDORPHIN; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE;

ANTAGONISM; DRUG; INHIBITION; INJURY; PATHOLOGY; SIGNAL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC PAIN; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; HYPERALGESIA; MOUSE; NOCICEPTIVE PAIN; NONHUMAN; PAW EDEMA; PLACE PREFERENCE; PRIORITY JOURNAL; SENSITIZATION; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; TISSUE INJURY; UPREGULATION;

ANIMALIA;

EID: 84884600291     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1239403     Document Type: Article

References (51)

1. A. Latremoliere, C. J. Woolf, J. Pain 10, 895-926 (2009).
2. H. Ikeda et al., Science 312, 1659-1662 (2006).
3. R. Ruscheweyh, O. Wilder-Smith, R. Drdla, X. G. Liu, J. Sandkühler, Mol. Pain 7, 20 (2011).
4. G. W. Terman, C. L. Eastman, C. Chavkin, J. Neurophysiol. 85, 485-494 (2001).
5. J. Benrath, C. Brechtel, E. Martin, J. Sandkühler, Anesthesiology 100, 1545-1551 (2004).
6. R. Drdla-Schutting, J. Benrath, G. Wunderbaldinger, J. Sandkühler, Science 335, 235-238 (2012).
7. A. I. Basbaum, H. L. Fields, Annu. Rev. Neurosci. 7, 309-338 (1984).
8. M. H. Ossipov, G. O. Dussor, F. Porreca, J. Clin. Invest. 120, 3779-3787 (2010).
9. M. J. Christie, Br. J. Pharmacol. 154, 384-396 (2008).
10. T. Avidor-Reiss, I. Nevo, D. Saya, M. Bayewitch, Z. Vogel, J. Biol. Chem. 272, 5040-5047 (1997).
11. S. B. Lane-Ladd et al., J. Neurosci. 17, 7890-7901 (1997).
12. R. Drdla, M. Gassner, E. Gingl, J. Sandkühler, Science 325, 207-210 (2009).
13. C. Heinl, R. Drdla-Schutting, D. N. Xanthos, J. Sandkühler, J. Neurosci. 31, 16748-16756 (2011).
14. E. J. Nestler, G. K. Aghajanian, Science 278, 58-63 (1997).
15. J. A. Kauer, R. C. Malenka, Nat. Rev. Neurosci. 8, 844-858 (2007).
16. M. S. Angst, J. D. Clark, Anesthesiology 104, 570-587 (2006).
17. Z. Wang, E. J. Bilsky, F. Porreca, W. Sadée, Life Sci. 54, PL339-PL350 (1994).
18. J. G. Liu, P. L. Prather, Mol. Pharmacol. 60, 53-62 (2001).
19. D. Wang et al., J. Pharmacol. Exp. Ther. 308, 512-520 (2004).
20. J. R. Shoblock, N. T. Maidment, Neuropsychopharmacology 31, 171-177 (2006).
21. F. J. Meye, R. van Zessen, M. P. Smidt, R. A. Adan, G. M. Ramakers, J. Neurosci. 32, 16120-16128 (2012).
22. J. R. Shoblock, N. T. Maidment, Neuroscience 149, 642-649 (2007).
23. E. M. Pogatzki, S. N. Raja, Anesthesiology 99, 1023-1027 (2003).
24. C. Luo, P. H. Seeburg, R. Sprengel, R. Kuner, Pain 140, 358-367 (2008).
25. S. Doolen, C. B. Blake, B. N. Smith, B. K. Taylor, Mol. Pain 8, 56 (2012).
26. D. M. Chetkovich, J. D. Sweatt, J. Neurochem. 61, 1933-1942 (1993).
27. V. Zachariou et al., Biol. Psychiatry 63, 1013-1021 (2008).
28. M. S. Mazei-Robison, E. J. Nestler, Cold Spring Harbor Perspect. Med. 2, a012070 (2012).
29. F. Wei et al., Neuron 36, 713-726 (2002).
30. H. Wang et al., Sci. Transl. Med. 3, 65ra3 (2011).
31. T. Kenakin, FASEB J. 15, 598-611 (2001).
32. T. Kenakin, Trends Pharmacol. Sci. 25, 186-192 (2004).
33. T. Costa, A. Herz, Proc. Natl. Acad. Sci. U.S.A. 86, 7321-7325 (1989).
34. R. Seifert, K. Wenzel-Seifert, Naunyn Schmiedebergs Arch. Pharmacol. 366, 381-416 (2002).
35. K. M. Raehal et al., J. Pharmacol. Exp. Ther. 313, 1150-1162 (2005).
36. W. Sadée, D. Wang, E. J. Bilsky, Life Sci. 76, 1427-1437 (2005).
37. H. Lam et al., Mol. Pain 7, 24 (2011).
38. J. G. Liu, M. B. Ruckle, P. L. Prather, J. Biol. Chem. 276, 37779-37786 (2001).
39. T. King et al., Nat. Neurosci. 12, 1364-1366 (2009).
40. Y. He, X. Tian, X. Hu, F. Porreca, Z. J. Wang, J. Pain 13, 598-607 (2012).
41. K. J. Sufka, Pain 58, 355-366 (1994).
42. G. F. Koob, R. Maldonado, L. Stinus, Trends Neurosci. 15, 186-191 (1992).
43. B. Kest et al., Neuroscience 115, 463-469 (2002).
44. M. N. Asiedu et al., J. Neurosci. 31, 6646-6653 (2011).
45. M. De Felice et al., Brain 133, 2475-2488 (2010).
46. C. Rivat et al., Neuropsychopharmacology 32, 2217-2228 (2007).
47. M. Zhuo, Drug Discov. Today 17, 573-582 (2012).
48. S. Li et al., Mol. Pharmacol. 70, 1742-1749 (2006).
49. H. C. Lu et al., Nat. Neurosci. 6, 939-947 (2003).
50. H. Xu et al., J. Neurosci. 28, 7445-7453 (2008).
51. C. Rivat et al., Anesthesiology 96, 381-391 (2002).